Dr. Joshua A. Feinberg

Joshua A. Feinberg M.D., F.A.C.S is an attending breast surgical oncologist and the Director of Clinical Research in the Division of Breast Surgery at Maimonides Medical Center in Brooklyn, NY. Dr. Feinberg completed a one-year research fellowship in Evidenced-Based Practice and Patient Safety under the mentorship of Professor Peter McCulloch at Oxford University. Drawing upon his surgical innovation work with the IDEAL Collaboration, Dr. Feinberg is currently the primary investigator on several multi-center clinical trials, evaluating surgical devices and technologies in the field of breast surgical oncology.

Current IDEAL Projects

"Standardizing Outcome Reporting and Technique Variations in Nipple-Areolar Complex Neurotization After Nipple-Sparing Mastectomy." Current literature on NAC neurotization is at IDEAL framework stage 2A, limited to small cohort studies with heterogeneous techniques and outcome measures. This is a prospective registry database to capture both technical variations and outcomes of NAC neurotization performed during NSM.

Relevant Publications

McCulloch P., Feinberg, J., Beyond IDEAL: the importance of surgical innovation metrics – Author’s reply. Lancet. Volume 393, Issue 10169, p16, January 26, 2019

McCulloch P., Feinberg, J. Progress in clinical research in surgery and IDEAL. Lancet. Volume 392, Issue 10141, p88-94, July 07, 2018.

Hirst A., Philippou Y., Blazeby J., Campbell B., Campbell M., Feinberg J., et al. No surgical innovation without evaluation: Evolution and further development of the IDEAL framework and recommendations. Annals of Surgery, p1-10. April 24, 2018.